|
The Clown Show: trade biotechs & more
|
![]() |
![]() ![]() |
![]() |
|
||
![]() |
![]() |
Re: GBIOIt speaks to how challenging it is to raise money in the current environment. They gave up future revenue for the $40M and they’ll give up equity for the $36M. The market cap went up $67M which is what you’d expect if you received $67M with no strings attached. Companies like PAVM and SGMO may bite the dust. This may hold them over until things improve. |
![]() ![]() ![]() ![]() |
return to message board, top of board |